Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alcon Inc
(NY:
ALC
)
79.04
+0.12 (+0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 9, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Alcon Inc
< Previous
1
2
Next >
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
May 22, 2023
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Alcon Advances Company’s Social Impact Through Global Volunteerism
May 22, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Reports First Quarter 2023 Results
May 09, 2023
From
Alcon Inc. Investors
Via
Business Wire
New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision
May 06, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Results of 2023 Annual General Meeting
May 05, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity
May 01, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Publishes Agenda for 2023 Annual General Meeting
March 29, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award
March 23, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Alcon to Host 2023 Capital Markets Day
March 20, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023
March 01, 2023
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Reports Fourth Quarter and Full Year 2022 Results
February 27, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices
February 12, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism
January 05, 2023
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference
December 28, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Prices US$1.3 Billion Senior Notes Offering
November 29, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
November 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Third Quarter 2022 Results
November 15, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22
October 26, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022
September 29, 2022
From
Alcon Inc. Investors
Via
Business Wire
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
August 23, 2022
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of
Via
Spotlight Growth
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
August 22, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports Second Quarter 2022 Results
August 09, 2022
From
Alcon Inc. Investors
Via
Business Wire
Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday
June 06, 2022
From
Alcon Inc. Corporate
Via
Business Wire
Alcon Prices EUR 500.0 Million Senior Notes Offering
May 24, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
May 23, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Reports First Quarter 2022 Results
May 10, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon Announces Results of 2022 Annual General Meeting
April 27, 2022
From
Alcon Inc. Investors
Via
Business Wire
Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries
April 23, 2022
From
Alcon Inc. Corporate
Via
Business Wire
Alcon to Deliver Robust Scientific Program at ASCRS 2022
April 20, 2022
From
Alcon Inc. Investors
Via
Business Wire
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
April 08, 2022
From
Alcon Inc. Corporate
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.